Jaguar Health, Inc 10-Q for FY2026 Q1
Jaguar Health, Inc. (JAGX)
10-Q
2026-05-20
For: 2026-03-31
View Original
Added on
May 20, 2026
About this 10-Q
Jaguar Health, Inc filed this 10-Q on May 20, 2026, covering the quarter ended March 31, 2026 (FY2026 Q1).
Headline figures
Quarter ended March 31, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $20.27M
- up 815.6% from $2.21M a year earlier
- Net income
- $8.72M
- compared with a net loss of $10.6M a year earlier
- Diluted EPS
- -$13.60
- compared with -$584.45 a year earlier